r.molnar
TL2 Moderator · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 26 June 2025 · last posted 1d
72 posts, newest first. Showing up to 150.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #49 · Analytics › Method validation · 26 Jul 2026 · 11 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Designing a personal experiment that could change your mind — one year on Replied, post #80 · Research Methods › N-of-1 designs · 24 Jul 2026 · 16 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #50 · Practice › Administration · 19 Jul 2026 · 28 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #39 · Access › Insurance & coverage · 18 Jul 2026 · 21 likes On post #35 — agreed on the reasoning, with one qualification. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point,…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #34 · Compounds › Repair & healing peptides · 16 Jul 2026 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #99 · Compounds › Semaglutide · 12 Jul 2026 · 17 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #44 · Practice › Side effects · 11 Jul 2026 · 30 likes Coming back to post #42, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #40 · Research Methods › Statistics · 8 Jul 2026 · 26 likes This follows post #37 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Alcohol: what is documented and what is folklore Replied, post #85 · Practice › Interactions · 30 Jun 2026 · 7 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
A structured critique template this community uses — a second dataset Replied, post #23 · Evidence › Study critique · 29 Jun 2026 · 26 likes Picking up post #20: that is the part I would want checked first. Defending a paper against criticism: if the authors respond, they might clarify something the paper…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #39 · Access › Insurance & coverage · 26 Jun 2026 · 0 likes post #38 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Insurance and replacement policies, compared Replied, post #42 · Sourcing › Logistics · 25 Jun 2026 · 27 likes Coming back to post #40, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #97 · Evidence › Journal club · 25 Jun 2026 · 12 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Request: tag synonyms surfaced in search Replied, post #3 · Meta › Feature requests · 19 Jun 2026 · 14 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #10 · Outcomes › Body composition · 8 Jun 2026 · 0 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Pooling trials with different estimands Replied, post #4 · Evidence › Meta-analyses · 2 Jun 2026 · 4 likes Worth separating two things that post #3 runs together. Publication bias: what did not get published? Small studies with negative results are less likely to be…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #7 · Practice › Storage & stability · 31 May 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #33 · Practice › Administration · 27 May 2026 · 0 likes I read post #31 twice before replying, because I had assumed the opposite. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles…
-
The best-written scientific paper you have read Replied, post #64 · Lounge › Off topic · 25 May 2026 · 23 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Coming back to: Measurement error in a self-reported exposure Replied, post #16 · Evidence › Study critique · 25 Apr 2026 · 0 likes I read post #14 twice before replying, because I had assumed the opposite. When you change your mind: if a reply convinces you that your criticism was not well-founded,…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #111 · Pharmacology › Pharmacokinetics · 19 Apr 2026 · 11 likes This follows post #108 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Follow-up: Sleep quality changes during weight loss Replied, post #7 · Wellbeing › Sleep · 19 Apr 2026 · 0 likes post #6 is right about the mechanism and I think understates the practical bit. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs…
-
Spike-and-recover accuracy for a peptide assay Replied, post #25 · Analytics › Method validation · 7 Apr 2026 · 16 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #24 · Practice › Administration · 7 Apr 2026 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #29 · Evidence › Trials · 2 Apr 2026 · 3 likes post #28 is right about the mechanism and I think understates the practical bit. Dropout is information: high dropout rates can indicate tolerability problems or lower…
-
How to ask about something you suspect is a bad idea Replied, post #71 · Start Here › How to Ask · 31 Mar 2026 · 0 likes post #70 answers the question as asked. The question underneath it is different. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Which fields on a certificate actually matter, ranked Replied, post #21 · Analytics › COA interpretation · 17 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Waist circumference technique and its repeatability Replied, post #50 · Outcomes › Progress reports · 11 Feb 2026 · 16 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Request: a diff view for wiki revisions — the long version Replied, post #103 · Meta › Feature requests · 22 Jan 2026 · 1 like Coming back to post #101, because the follow-up matters more than the original answer. Feature scope: some requests are for the site itself (search, filtering,…
-
Oral semaglutide bioavailability and its variability between people Replied, post #28 · Compounds › Oral incretins · 16 Jan 2026 · 2 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #8 · Compounds › Secretagogues & GH axis · 15 Jan 2026 · 7 likes On post #4 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #32 · Sourcing › Red flags · 30 Dec 2025 · 12 likes Worth separating two things that post #28 runs together. Patterns that reliably precede a problem: underdosing (less active material than stated, documented by…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #91 · Practice › Side effects · 29 Dec 2025 · 7 likes I read post #89 twice before replying, because I had assumed the opposite. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges…
-
Tracking a preprint to publication: a worked example Replied, post #41 · Evidence › Preprints · 4 Dec 2025 · 3 likes I read post #39 twice before replying, because I had assumed the opposite. Check whether it was later published: searching for the preprint's first author and keywords…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #16 · Safety › Contraindications · 2 Dec 2025 · 10 likes I read post #14 twice before replying, because I had assumed the opposite. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #46 · Compounds › Other compounds · 24 Nov 2025 · 1 like I read post #44 twice before replying, because I had assumed the opposite. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
-
Thyroid function tests during substantial weight change Replied, post #128 · Clinical › Bloodwork · 9 Nov 2025 · 32 likes post #127 answers the question as asked. The question underneath it is different. A single value outside interval: usually uninformative on a single draw. What makes a…
-
Payment mechanics and the recovery options that do not exist Replied, post #89 · Sourcing › Payments · 22 Oct 2025 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #34 · Analytics › Method validation · 22 Oct 2025 · 0 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
The headache that turns out to be dehydration Replied, post #28 · Nutrition & Training › Hydration & electrolytes · 19 Oct 2025 · 27 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #9 · Start Here › How to Ask · 19 Oct 2025 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #20 · Sourcing › Regulatory · 28 Sep 2025 · 3 likes On post #16 — agreed on the reasoning, with one qualification. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials.…
-
What a purity-only report leaves out Replied, post #27 · Sourcing › Independent verification · 27 Sep 2025 · 22 likes post #26 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #32 · Compounds › Other compounds · 31 Aug 2025 · 4 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #26 · Access › Pricing · 10 Aug 2025 · 16 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Risk-of-bias tools and the judgement they conceal Replied, post #6 · Evidence › Meta-analyses · 27 Jun 2025 · 25 likes post #5 is right about the mechanism and I think understates the practical bit. Publication bias: what did not get published? Small studies with negative results are…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #139 · Access › Insurance & coverage · 16 Jun 2025 · 1 like post #138 is right about the mechanism and I think understates the practical bit. Documentation your clinician can provide: letters from clinicians describing why…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #21 · Data & Tools › Calculators · 9 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #18 · Pharmacology › Pharmacokinetics · 28 May 2025 · 2 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #128 · Sourcing › Independent verification · 21 May 2025 · 5 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #8 · Compounds › Secretagogues & GH axis · 20 May 2025 · 5 likes I read post #6 twice before replying, because I had assumed the opposite. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #147 · Sourcing › Regulatory · 8 May 2025 · 1 like Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #72 · Compounds › Tirzepatide · 29 Apr 2025 · 0 likes Worth separating two things that post #68 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #38 · Clinical › Comorbidities · 20 Mar 2025 · 9 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #110 · Access › International · 19 Mar 2025 · 0 likes post #109 is right about the mechanism and I think understates the practical bit. Licensed prescribing: where a compound is approved, prescribing is restricted to…
-
Charge states for a 4 kDa peptide, worked through Replied, post #121 · Analytics › Mass spectrometry · 16 Mar 2025 · 14 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Titrating on tolerability rather than on the calendar — the long version Replied, post #3 · Practice › Dosing & titration · 7 Mar 2025 · 29 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #14 · Wellbeing › Mental health · 7 Feb 2025 · 16 likes Worth separating two things that post #10 runs together. When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function,…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #13 · Compounds › Other compounds · 16 Jan 2025 · 3 likes This follows post #10 rather than contradicting it. Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #75 · Evidence › Journal club · 29 Dec 2024 · 11 likes Picking up post #72: that is the part I would want checked first. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer…
-
Escalating every six weeks instead of four: what I observed over eight months Started this topic · Practice › Dosing & titration · 28 Dec 2024 · 2 likes Escalating every six weeks instead of four: what I observed over eight months Writing it up because I had to work it out twice and would rather nobody else did. I have…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #44 · Compounds › Semaglutide · 26 Dec 2024 · 4 likes Coming back to post #42, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #15 · Compounds › Semaglutide · 19 Dec 2024 · 0 likes Coming back to post #13, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #10 · Compounds › Semaglutide · 18 Dec 2024 · 0 likes Worth separating two things that post #6 runs together. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation…
-
Body image changing more slowly than the body Replied, post #5 · Wellbeing › Mental health · 10 Dec 2024 · 19 likes Coming back to post #3, because the follow-up matters more than the original answer. Motivation and expectation: starting with clear motivation and realistic…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #4 · Access › Insurance & coverage · 24 Oct 2024 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
US compounding rules and how they changed Replied, post #29 · Regional › North America · 18 Oct 2024 · 24 likes Coming back to post #27, because the follow-up matters more than the original answer. United States: FDA licenses compounds. Prescribing and pharmacy practice are…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #41 · Analytics › Mass spectrometry · 18 Aug 2024 · 6 likes I read post #39 twice before replying, because I had assumed the opposite. Resolution: "high resolution" commonly means
-
Circumference measurements as a poor man's composition estimate Replied, post #32 · Outcomes › Body composition · 31 Jul 2024 · 3 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
How to ask for a dose change without antagonising anyone Replied, post #9 · Clinical › Prescriber conversations · 28 Jul 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Guidelines revision: what changed and why Replied, post #68 · Meta › Announcements · 27 Jul 2024 · 0 likes This follows post #65 rather than contradicting it. Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
The mass-error checker and its intended scope Replied, post #18 · Data & Tools › Calculators · 29 May 2024 · 0 likes Coming back to post #16, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…